— Know what they know.
Not Investment Advice

XCUR NASDAQ

Exicure, Inc.
1W: -10.8% 1M: -23.3% 3M: -21.0% YTD: -48.2% 1Y: -71.3% 3Y: -40.2% 5Y: -98.8%
$2.89
-0.17 (-5.56%)
Pre-Market: $2.85 (-0.04, -1.38%)
Weekly Expected Move ±7.4%
$2 $3 $3 $3 $3
NASDAQ · Healthcare · Biotechnology · Alpha Radar Strong Sell · Power 21 · $18.4M mcap · 2M float · 1.02% daily turnover · Short 32% of daily vol
Last Earnings 2026-03-25
EPS
$-0.46
▲ Beat +97.5%
Revenue
$2M
Est (actual pending)
Next Earnings 2026-08-07
EPS Estimate
$-21.00
Range: $-21.00 - $-21.00
Revenue Estimate
$2M
1 analysts

Estimate vs Actual

Earnings Surprise History

3/18
EPS Beats
2/18
Revenue Beats
17%
EPS Beat Rate
11%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-03-30 quarter 2025-12-31 $— $-18.60 ▼ 18.60 $— $1,644,250
2026-03-30 quarter 2027-12-31 $— $-0.95 ▼ 0.95 $— $3,900,000
2026-03-30 quarter 2027-09-30 $-0.95 $-4.50 ▼ 3.55 $3,900,000 $3,900,000
2026-03-30 quarter 2027-06-30 $-4.50 $-6.00 ▼ 1.50 $3,900,000 $4,099,999
2026-03-30 quarter 2027-03-31 $— $-10.50 ▼ 10.50 $— $4,300,000
2026-03-30 quarter 2026-12-31 $— $-21.00 ▼ 21.00 $— $3,500,000
2026-03-30 quarter 2026-09-30 $-21.00 $-13.88 ▲ 7.12 $3,500,000 $6,988,250
2026-03-30 quarter 2026-06-30 $-13.88 $-21.00 ▼ 7.12 $6,988,250 $1,552,600
2026-03-30 quarter 2028-03-31 $— $-6.00 ▼ 6.00 $— $4,099,999
2026-03-30 quarter 2026-03-31 $— $-18.60 ▼ 18.60 $— $1,644,250
2026-03-30 quarter 2025-09-30 $— $-0.95 ▼ 0.95 $— $3,900,000
2026-03-30 quarter 2025-06-30 $— $-4.50 ▼ 4.50 $— $3,900,000
2026-03-30 quarter 2025-03-31 $— $-6.00 ▼ 6.00 $— $4,099,999
2026-03-30 quarter 2024-12-31 $— $-10.50 ▼ 10.50 $— $4,300,000
2026-03-30 quarter 2024-09-30 $— $-21.00 ▼ 21.00 $— $3,500,000
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms